These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12653481

  • 1. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
    Moser C, Schmidbauer C, Gürtler U, Gross C, Gehrmann M, Thonigs G, Pfister K, Multhoff G.
    Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
    [Abstract] [Full Text] [Related]

  • 2. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G.
    Clin Cancer Res; 2004 Jun 01; 10(11):3699-707. PubMed ID: 15173076
    [Abstract] [Full Text] [Related]

  • 3. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
    Gross C, Hansch D, Gastpar R, Multhoff G.
    Biol Chem; 2003 Feb 01; 384(2):267-79. PubMed ID: 12675520
    [Abstract] [Full Text] [Related]

  • 4. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
    Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.
    Cell Stress Chaperones; 2008 Feb 01; 13(2):221-30. PubMed ID: 18759005
    [Abstract] [Full Text] [Related]

  • 5. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.
    Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, Multhoff G.
    J Immunol; 2004 Jan 15; 172(2):972-80. PubMed ID: 14707070
    [Abstract] [Full Text] [Related]

  • 6. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.
    Gross C, Schmidt-Wolf IG, Nagaraj S, Gastpar R, Ellwart J, Kunz-Schughart LA, Multhoff G.
    Cell Stress Chaperones; 2003 Jan 15; 8(4):348-60. PubMed ID: 15115287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
    Milani V, Stangl S, Issels R, Gehrmann M, Wagner B, Hube K, Mayr D, Hiddemann W, Molls M, Multhoff G.
    J Transl Med; 2009 Jun 23; 7():50. PubMed ID: 19549307
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity.
    Multhoff G, Pfister K, Gehrmann M, Hantschel M, Gross C, Hafner M, Hiddemann W.
    Cell Stress Chaperones; 2001 Oct 23; 6(4):337-44. PubMed ID: 11795470
    [Abstract] [Full Text] [Related]

  • 12. Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells.
    Stangl S, Wortmann A, Guertler U, Multhoff G.
    J Immunol; 2006 May 15; 176(10):6270-6. PubMed ID: 16670338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R, Wei H, Zhang J, Li A, Zhang W, Tian Z.
    Neuroimmunomodulation; 2006 May 15; 10(3):169-76. PubMed ID: 12481157
    [Abstract] [Full Text] [Related]

  • 16. A 14-mer peptide from HSP70 protein is the critical epitope which enhances NK activity against tumor cells in vivo.
    Zhang H, Liu R, Huang W.
    Immunol Invest; 2007 May 15; 36(3):233-46. PubMed ID: 17558707
    [Abstract] [Full Text] [Related]

  • 17. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
    Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G.
    Cancer Res; 2005 Jun 15; 65(12):5238-47. PubMed ID: 15958569
    [Abstract] [Full Text] [Related]

  • 18. Nucleofection of non-B cells with mini-Epstein-Barr virus DNA.
    Radons J, Gross C, Stangl S, Multhoff G.
    J Immunol Methods; 2005 Aug 15; 303(1-2):135-41. PubMed ID: 16055146
    [Abstract] [Full Text] [Related]

  • 19. Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.
    Shevtsov M, Pitkin E, Ischenko A, Stangl S, Khachatryan W, Galibin O, Edmond S, Lobinger D, Multhoff G.
    Front Immunol; 2019 Aug 15; 10():454. PubMed ID: 30967859
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M.
    Transplant Proc; 2004 Oct 15; 36(8):2511-2. PubMed ID: 15561299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.